STAT News, February 1, 2018
Ike Swetlitz reporting on Holly Fernandez Lynch (Former Executive Director and Academic Fellow Alumna)


Read the Full Article

From the article:

Dozens of doctors, medical ethicists, and lawyers are warning Congress that legislation to allow Americans with life-threatening conditions access to unapproved, experimental drugs risks harming patients’ health.

The letter was drafted by Alison Bateman-House, associate professor of medical ethics at NYU Langone Health, along with some of her colleagues. It is addressed to the leaders of the House Committee on Energy and Commerce, the committee currently considering a so-called “right-to-try” bill. The letter was circulated for online signatures on Thursday, and organizers said they planned to send the letter on Feb. 5.

The Senate passed a right-to-try bill in August, which would allow patients with life-threatening conditions access to drugs that have not been approved by the Food and Drug Administration. The bill is now sitting in a House committee. FDA Commissioner Scott Gottlieb has expressed reservations about the bill, but President Trump seems to support it.

The 40-plus signatories of the draft letter, however, say they are strongly opposed. [...]

Read full article here!

bioethics clinical research health law policy medical safety pharmaceuticals public health regulation